Aidoc has received FDA Breakthrough Device status for its AI solution that flags multiple critical conditions in CT scans.
Key Details
- 1Aidoc's new AI product can detect a variety of urgent, life-threatening conditions from CT scans.
- 2The solution operates within a single workflow, streamlining triage for radiologists.
- 3This is believed to be the first FDA Breakthrough Device designation for an AI covering such a broad scope in one tool.
- 4The FDA Breakthrough Device Program is intended to speed market access for innovative medical technologies.
Why It Matters
Breakthrough Device status can accelerate regulatory review, paving the way for faster clinical adoption of comprehensive triage AI tools. This could improve patient outcomes by expediting the detection and management of critical conditions.
Source
Radiology Business
Related News
•Radiology Business
AI Triage Cuts CT Report Turnaround for Pulmonary Embolism—Daytime Only
FDA-backed study finds AI triage tools reduce radiology CT report turnaround times for pulmonary embolism during peak hours.
•Health Imaging
BMI Significantly Impacts AI Accuracy in CT Lung Nodule Detection
New research demonstrates that high BMI negatively impacts both human and AI performance in chest low-dose CT interpretation, highlighting dataset diversity concerns.
•Radiology Business
Higher BMI May Reduce AI and Human Accuracy on CT Scans
New research finds increased patient BMI can negatively impact AI performance on low-dose CT scans.